MILWAUKEE, WI, November 09, 2010 (Press-News.org) Innovative Custom Products, Inc. (ICP), owner of CureCeuticals, announced today its new invention, CureCeuticals' All-Natural Kills Ticks Specimen Drops.
According to Sherry Williams, Vice President, CureCeuticals' All-Natural Kills Ticks Specimen Drops start working on contact and kill a tick in about 90 seconds. She said the product contains no DEET, no chemicals, no synthetic ingredients and is completely safe. It comes in a small, convenient pocket-size vial that doubles as a "tick specimen receptacle". Williams said the product is simple to use, safe and effective. One drop directly on the tick disables the tick in seconds causing it to "release" and within 90 seconds the tick is dead. The tick is then placed in the vial as a "Tick Specimen" for a doctor's examination in case of tick disease or infection. Once the tick is placed in the vial, it should be disposed of safely and properly or brought to a doctor for examination.
The company also offers a safe and all-natural skin and surface spray, CureCeuticals' All-Natural Ticks Off Spray, used as a pre-post treatment for humans and animals who frequent wooded areas or farms, and it can also be applied to the skin immediately after removal of a tick. It can also be sprayed on carpets, clothes, and over the entire body. Williams said that both products contain the company's proprietary all-natural Citro-V Manuka Honey blend. Manuka Honey is scientifically proven for its antibacterial, antimicrobial, antiseptic, and anti-MRSA (Methicillin Rresistant Staphylococcus Aureus, a bacterial infection that is highly resistant to some antibiotics) properties. To learn more, visit http://bio.waikato.ac.nz/honey/.
According to Williams, ticks carry various diseases, are annoying parasites, and are difficult to kill without the use of potentially toxic and deadly chemicals. Our research identified no other all-natural, chemical-free commercially available product that is as safe and effective as CureCeuticals' All-Natural Kills Ticks Specimen Drops. The product is 100% natural, contains no DEET, environmentally friendly, safe and bio-degradable.
Williams said that international distributors are being assigned for worldwide distribution but in the mean time, the product is available in a 3-pack vial for $14.95 and can be purchased at the company's online store www.drmistICP.com and will be available at Amazon.com:
http://www.amazon.com/gp/search/ref=sr_nr_seeall_16?rh=k%3Acureceutic ... 1288991276
She said CureCeuticals' All-Natural Kills Ticks Drops is currently being presented to retail and sports stores, mass merchants, and pet stores nationwide and should soon be available at the register check-out lane for about $4.99 a vial. The company's companion product, CureCeuticals' All-Natural Ticks Off Spray retails for $16.95 for a 12-ounce bottle and is also available at the company's online store and at Amazon. The company expects robust sales for both products and is ramping up production to meet the anticipated demand.
CureCeuticals is a brand owned by Innovative Custom Products, Inc. (ICP), a Wisconsin corporation in business since 1992, and a distributor of consumer natural pharmaceutical and skin care products and can be contacted at: contact@icpCorporation.com or at (414) 358-1802 or visit the corporate website www.icpCorporation.com.
CureCeuticals Invents All-Natural Kills Ticks Drops: One Drop Kills Tick in 90 Seconds; No DEET, No Chemicals
According to Sherry Williams, Vice President, CureCeuticals' All-Natural Kills Ticks Specimen Drops start working on contact and kill a tick in about 90 seconds. The product contains no DEET, no chemicals, no synthetic ingredients and is completely safe.
2010-11-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Stanley Morgan & Associates Announces Quick Pay Program to Creditors for Holidays
2010-11-09
Stanley, Morgan & Associates, the country's leading collection association, announces plans to unveil its Quick Pay Program just in time for the holiday season.
Given present economical conditions, the reps at Stanley, Morgan & Associates understand time is money and having to wait for a check from your collection agency can mean the difference between expanding your wish list and keeping your doors open in the coming months. In an effort to place remittances in the clients' hands as quickly as possible, Stanley, Morgan & Associates announces the "Quick Pay Program" ...
The deVere Group Announces Sponsorship of Chris Foot's Historic South Pole Expedition - First Solo Polar Expeditionist to Travel 1392 Miles Unsupported and Unassisted
2010-11-09
The deVere Group, the world's largest independent financial consultancy group, was announced lead sponsor of Chris Foot in his quest to become the first polar expeditionist to travel 1392 miles solo unsupported and unassisted.
The deVere Group is sponsoring Chris GBP20,000 to aid the costs of the equipment for the expedition. In addition, deVere employees are raising money across the globe for Combat Stress.
This epic route is the only remaining conquest in Antarctica not to be claimed by an expeditionist. Chris will be in partnership with Combat Stress throughout ...
Joint pain linked to breast cancer drug not inflammatory arthritis or autoimmune disease
2010-11-08
Washington, DC -- A new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory arthritis or autoimmune disease. Because of that, researchers say women who were primarily concerned about the threat of arthritis should be encouraged to continue taking the medication. The findings of the study will be presented Tuesday, Nov. 9 at the 74th Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia
For many post-menopausal women with breast cancer promoted by the ...
Georgetown study: Scleroderma dramatically under-diagnosed with commercial screening method
2010-11-08
Washington, DC -- New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia.
The American College of Rheumatology recommends immunofluorescence antinuclear antibody (IF-ANA) testing to help detect the presence of scleroderma specific antinuclear antibodies. ...
Studying the metabolome of smokers, Lombardi researchers find early signs of damage
2010-11-08
Philadelphia, Pa. – Examining the blood "metabolomics" profile of smokers immediately after they had a cigarette revealed activation of pathways involved in cell death, inflammation, and other forms of systemic damage, say researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center.
They say their findings, presented at the Ninth AACR Frontiers in Cancer Prevention Research Meeting, is the best analysis for chemicals unequivocally produced by smoking and indicates the potential toll that carcinogens and toxins poise to ...
Study: Tai Chi relieves arthritis pain, improves reach, balance, well-being
2010-11-08
CHAPEL HILL, N.C. – In the largest study to date of the Arthritis Foundation's Tai Chi program, participants showed improvement in pain, fatigue, stiffness and sense of well-being.
Their ability to reach while maintaining balance also improved, said Leigh Callahan, PhD, the study's lead author, associate professor in the University of North Carolina at Chapel Hill School of Medicine and a member of UNC's Thurston Arthritis Research Center.
"Our study shows that there are significant benefits of the Tai Chi course for individuals with all types of arthritis, including ...
McMaster scientists turn skin into blood
2010-11-08
Hamilton, ON (November 7, 2010) – In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.
The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anemia will be able to have blood created from a patch of their own skin to provide transfusions. Clinical trials could begin as soon as 2012.
Mick Bhatia, scientific director of McMaster's Stem Cell ...
Hospital for Special Surgery scientists share advances in lupus and related conditions
2010-11-08
Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR).
Special Surgery investigators will present advances that may influence the future of clinical care. Topics include prevention strategies for helping orthopedic patients avoid falls, quality of life in children with lupus, understanding joint pain caused by a commonly used breast cancer medication, lupus-related ...
New insect birth control strategy zaps cotton pests
2010-11-08
Using pests as part of an insect birth control program helps to get rid of them, UA researchers find. A new approach that combines the planting of pest-resistant cotton and releasing large numbers of sterile moths has virtually eliminated of the world's most destructive cotton pests from Arizona.
The novel control strategy, published in the Nov. 7 advance online publication of the journal Nature Biotechnology, has allowed growers to maintain high cotton yields without spraying insecticides to control pink bollworm.
"We are running the pesticide treadmill in reverse," ...
Statins don't prove useful for general pediatric lupus population
2010-11-08
ATLANTA, GA — Lupus puts children at higher risk for coronary artery disease when they become adults, but routinely using statins doesn't provide enough benefit to warrant their regular use in children and adolescents, according to the largest study of pediatric lupus patients to date.
Lupus is an autoimmune disease that causes widespread inflammation and organ damage. Children with lupus show early signs of atherosclerosis -- the fatty tissue buildup that is the precursor to clogged arteries. Previous research also indicates risk for heart attack and stroke in premenopausal ...
LAST 30 PRESS RELEASES:
Label distribution similarity-based noise correction for crowdsourcing
The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050
Diabetes medication may be effective in helping people drink less alcohol
US over 40s could live extra 5 years if they were all as active as top 25% of population
Limit hospital emissions by using short AI prompts - study
UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research
Fayetteville police positive about partnership with social workers
Optical biosensor rapidly detects monkeypox virus
New drug targets for Alzheimer’s identified from cerebrospinal fluid
Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment
Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H
Firefighters exposed to chemicals linked with breast cancer
Addressing the rural mental health crisis via telehealth
Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis
Researchers shed light on skin tone bias in breast cancer imaging
Study finds humidity diminishes daytime cooling gains in urban green spaces
Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards
AI tool ‘sees’ cancer gene signatures in biopsy images
Answer ALS releases world's largest ALS patient-based iPSC and bio data repository
2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller
Slow editing of protein blueprints leads to cell death
Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall
Emerging alternatives to reduce animal testing show promise
Presenting Evo – a model for decoding and designing genetic sequences
Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions
Industrial snow: Factories trigger local snowfall by freezing clouds
Backyard birds learn from their new neighbors when moving house
New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050
Breakthrough in capturing 'hot' CO2 from industrial exhaust
New discovery enables gene therapy for muscular dystrophies, other disorders
[Press-News.org] CureCeuticals Invents All-Natural Kills Ticks Drops: One Drop Kills Tick in 90 Seconds; No DEET, No ChemicalsAccording to Sherry Williams, Vice President, CureCeuticals' All-Natural Kills Ticks Specimen Drops start working on contact and kill a tick in about 90 seconds. The product contains no DEET, no chemicals, no synthetic ingredients and is completely safe.